Skip to Main Content

Paper Details

Integrative Mendelian randomization reveals the soluble receptor for advanced glycation end products as protective in relation to rheumatoid arthritis.
Sci Rep
1
2023
AGER, CVD, RA, RAGE, RF, Rheumatoid arthritis, atherosclerotic cardiovascular diseases, genetic variants, participants, rheumatoid arthritis, rheumatoid factor, sRAGE, soluble receptor for advanced glycation end products
Author NameAffiliation
Jiantao Ma
Jiantao MaTufts University
Roby Joehanesand Blood Institute, National Institutes of Health
Roby Joehanes
Chunyu Liu
Chunyu LiuSchool of Public Health, Boston University
Chunyu Liu
Chunyu LiuSchool of Public Health, Boston University
Daniel Levyand Blood Institute, National Institutes of Health
Daniel Levy
Daniel Levyand Blood Institute, National Institutes of Health
Daniel Levy
  • 1 - 12

Datasets

Release 1.2